CorMedix Inc. (CRMD) stock
CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.67−0.15 (-3.11%)
Close on Nov 17, 2026Market cap $364.00MP/E –Yield –
CorMedix operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
CorMedix's operating cash flow for the twelve months ending Jun 30, 2026 was $253.94M, up 733.6% year over year. For fiscal 2025 it was $175.05M. The highest annual figure on record is $175.05M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $175.05M | – |
| FY2024 | Dec 31, 2024 | -$50.62M | – |
| FY2023 | Dec 31, 2023 | -$38.41M | – |
| FY2022 | Dec 31, 2022 | -$24.36M | – |
| FY2021 | Dec 31, 2021 | -$21.16M | – |
| FY2020 | Dec 31, 2020 | -$21.97M | – |
| FY2019 | Dec 31, 2019 | -$15.05M | – |
| FY2018 | Dec 31, 2018 | -$23.70M | – |
| FY2017 | Dec 31, 2017 | -$28.59M | – |
| FY2016 | Dec 31, 2016 | -$22.27M | – |
| FY2015 | Dec 31, 2015 | -$12.53M | – |
| FY2014 | Dec 31, 2014 | -$6.32M | – |
| FY2013 | Dec 31, 2013 | -$3.62M | – |
| FY2012 | Dec 31, 2012 | -$2.28M | – |
| FY2011 | Dec 31, 2011 | -$6.30M | – |
| FY2010 | Dec 31, 2010 | -$3.67M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $86.24M | +187.5% |
| Q1 FY2026 | Mar 31, 2026 | $42.38M | +114.7% |
| Q4 FY2025 | Dec 31, 2025 | $94.46M | – |
| Q3 FY2025 | Sep 30, 2025 | $30.86M | – |
| Q2 FY2025 | Jun 30, 2025 | $29.99M | – |
| Q1 FY2025 | Mar 31, 2025 | $19.74M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.61M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.65M | – |
| Q2 FY2024 | Jun 30, 2024 | -$14.04M | – |
| Q1 FY2024 | Mar 31, 2024 | -$17.31M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.75M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.70M | – |
| Q2 FY2023 | Jun 30, 2023 | -$8.57M | – |
| Q1 FY2023 | Mar 31, 2023 | -$10.39M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.15M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.00M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.46M | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.74M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.87M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.50M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.09M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.69M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.93M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.31M | – |
| Q2 FY2020 | Jun 30, 2020 | -$754.37K | -558.7% |
| Q1 FY2020 | Mar 31, 2020 | -$7.97M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.88M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.96M | – |
| Q2 FY2019 | Jun 30, 2019 | $164.46K | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.37M | – |
| Q4 FY2018 | Dec 31, 2018 | -$7.20M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.11M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.34M | – |
| Q1 FY2018 | Mar 31, 2018 | -$7.05M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.28M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.80M | – |
| Q2 FY2017 | Jun 30, 2017 | -$7.75M | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.76M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.50M | – |
| Q3 FY2016 | Sep 30, 2016 | -$6.55M | – |
See a number that looks wrong?